Longevity Medicine
What Is Low-Dose CT for Lung Cancer?
Last reviewed: May 2026 · Haute MD Editorial Team
Low-dose CT (LDCT) is the only lung cancer screening modality proven in randomized trials to reduce lung cancer mortality, by approximately 20% in eligible high-risk adults. It uses substantially lower radiation than standard CT and detects lung cancers at earlier, more curable stages than chest X-ray or symptom-based diagnosis.
Who qualifies for LDCT screening
Current USPSTF guidelines (2021) recommend annual LDCT for adults aged 50-80 with a ≥20 pack-year smoking history who currently smoke or quit within the past 15 years. Pack-years are calculated as packs per day multiplied by years smoked (e.g., 1 pack/day for 20 years = 20 pack-years). Screening should stop once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or willingness to undergo curative lung surgery. Many longevity practices extend consideration to former smokers beyond 15 years, particularly those with additional risk factors (occupational exposures, family history, COPD), though this is off-guideline.
Why LDCT works
The National Lung Screening Trial (NLST, 2011) showed a 20% reduction in lung cancer mortality with three annual LDCT screens compared to chest X-ray. The Dutch-Belgian NELSON trial (2020) showed similar mortality reduction with longer follow-up. The mechanism is stage shift: LDCT detects lung cancers at stage I/II when 5-year survival exceeds 60-90%, rather than at stage IV when survival is ~10%. Radiation exposure is approximately 1-1.5 mSv per scan (versus 7 mSv for standard chest CT), comparable to roughly 6 months of natural background radiation. False positive rates are meaningful — ~25% of initial scans show indeterminate nodules requiring follow-up — but the Lung-RADS reporting system has substantially reduced unnecessary biopsies.
What to expect and decisions
(1) Discuss eligibility with a primary care or pulmonologist — Medicare and most commercial insurers cover LDCT for guideline-eligible patients; (2) Expect annual scans; missing years reduces benefit; (3) Most positive findings are benign nodules requiring serial CT follow-up over 6-24 months — not biopsy; (4) Combine LDCT with smoking cessation counseling — quitting reduces lung cancer risk much more than screening alone; (5) Discuss extension beyond 15 years post-quit with a physician if you have additional risk factors; (6) LDCT is not appropriate for never-smokers in routine screening — even though never-smokers can develop lung cancer, the prevalence is too low for screening to be net-beneficial in randomized trials. Lung cancer screening combined with sustained smoking cessation is one of the highest-yield interventions in middle-aged longevity care for eligible patients.
Frequently Asked Questions
How much does LDCT cost?
Covered by Medicare and most commercial insurers for guideline-eligible patients without copay as a preventive service. Out-of-pocket cost in the absence of coverage is typically $200-400 per scan.
What if I'm an ex-smoker beyond 15 years?
Guidelines do not recommend continued screening, but some longevity physicians extend screening based on individualized risk factors. Discuss with your physician — the evidence base for >15-year post-quit screening is limited.
Does LDCT detect cancers other than lung?
Yes — it commonly identifies coronary artery calcium (a strong cardiovascular risk marker), thyroid and adrenal nodules, and other incidental findings. Some are clinically valuable (CAC scoring); others generate workup without benefit.
Is the radiation dose dangerous?
LDCT delivers ~1-1.5 mSv per scan, similar to 6 months of background radiation. Cumulative risk over a screening lifetime is small relative to the mortality reduction in eligible patients. It is not advised for never-smokers because the benefit is too small to justify even modest radiation exposure.
Get Help Now
Speak with a Haute MD Longevity Medicine physician
Dr. George Kaltner
CEO
Longevity Medicine · Miami Beach, FL
View Profile
Dr. Alexander Golberg
Longevity Medicine · New York, NY
View Profile
Dr. Steven Victor
Regenerative Medicine Specialist
Longevity Medicine · New York, NY
View ProfileAre you a Longevity Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · LONGEVITY MEDICINE
What Is Preventive Oncology?
Preventive oncology applies risk stratification, advanced screening, and lifestyle interventions to detect cancer earlier and reduce lifetime cancer risk.
Read GuideGuide · LONGEVITY MEDICINE
What Is Multi-Cancer Early Detection?
Multi-cancer early detection (MCED) tests screen for dozens of cancers from a single blood sample using DNA methylation signatures.
Read GuideGuide · LONGEVITY MEDICINE
What Is Liquid Biopsy?
Liquid biopsy is a blood test that detects circulating tumor DNA and other cancer-derived material to enable earlier detection and monitoring.
Read Guide